PineTree Therapeutics is a pre-clinical stage Biotech company headquartered in Cambridge, MA and was founded in 2019. It has developed the TAER-TAB™ and ViTRAP™ technologies and is building a broad pipeline for hard-to-treat cancers and viral diseases, with an initial focus on oncology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/07/22 | $23,500,000 | Series A-1 |
DSC Investment InterVest Samho Green Investment SJ Investment Partners SK Securities | undisclosed |
